Evidence map›Paper›PMID 37181656›Full record

ArticleComputational and structural biotechnology journal2023

Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy.

Yumei Ning, Kun Lin, Jun Fang, Yang Ding, Zhang Zhang, Xiaojia Chen, Qiu Zhao, Haizhou Wang, Fan Wang

Open access · goldAbstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Neuroimmunophysiology of the gastrointestinal tract.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yumei NingDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Kun LinDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jun FangDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yang DingDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhang ZhangDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xiaojia ChenDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Qiu ZhaoDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Haizhou WangDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Fan WangDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal (GI) cancers are a heterogeneous group of primary solid tumors, arising in GI tract from the esophagus to rectum. Matrix stiffness (MS) is a critical physical factor for cancer progression; however, its importance in tumor progression remains to be comprehensively recognized. Herein, we conducted a comprehensive pan-cancer analysis of MS subtypes across seven GI-cancer types. Using unsupervised clustering based on literature-derived MS-specific pathway signatures, the GI-tumor samples were divided into three MS subtypes, termed as the Soft, Mixed and Stiff. Then, distinct prognoses, biological features, tumor microenvironments and mutation landscapes among three MS subtypes were revealed. The Stiff tumor subtype was associated with the poorest prognosis, the most malignant biological behaviors, and the immunosuppressive tumor stromal microenvironment. Furthermore, multiple machine learning algorithms were used to develop an 11-gene MS-signature to identify the MS subtypes of GI-caner and predict chemotherapy sensitivity, which were further validated in two external GI-cancer cohorts. This novel MS-based classification on GI-cancers could enhance our understanding of the important role of MS in tumor progression, and may have implications for the optimization of individualized cancer management.

Indexed as

Cancer subtypeChemotherapyExtracellular matrixGastrointestinal cancerMatrix stiffness

Identifiers

PMID37181656
PMCPMC10173364
OpenAlexW4366490430

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.